CSL Ltd 2023 AR2

The report highlights CSL's strong performance for the fiscal year 2022-2023, driven by record levels of plasma collections and the successful integration of CSL Vifor. The company achieved significant milestones, including the launch of HEMGENIX, the first gene therapy for haemophilia B, and the opening of new state-of-the-art R&D facilities in Melbourne, Marburg, and Waltham. CSL also advanced its sustainability strategy by submitting near-term carbon emission reduction targets to the Science Based Targets initiative for validation. Additionally, the company purchased 100% renewable electricity across its European manufacturing facilities and expanded its global community investments.

Company: CSL Ltd

Sector: Health Care

Country: Australia

Year: 2023

Type: AR2

Pages: 172

CSL Ltd 2023 Annual Report

Annual Report

The report highlights CSL's strong performance for the fiscal year 2022-2023, driven by record levels of plasma collections and the successful integration of CSL Vifor. The company achieved significant milestones, including the launch of HEMGENIX, the first gene therapy for haemophilia B, and the opening of new state-of-the-art R&D facilities in Melbourne, Marburg, and Waltham. CSL also advanced its sustainability strategy by submitting near-term carbon emission reduction targets to the Science Based Targets initiative for validation. Additionally, the company purchased 100% renewable electricity across its European manufacturing facilities and expanded its global community investments.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2023

Reporting Period

Jul 1, 2022 - Jun 30, 2023

Fiscal Year

2023

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Energy Consumption

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Employees